echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Roche's world's first accelerator launched in Shanghai

    Roche's world's first accelerator launched in Shanghai

    • Last Update: 2021-07-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On May 18, Roche China Accelerator was officially launched in Shanghai Zhangjiang High-tech Roche Park
    .
    At the launching ceremony, Roche signed strategic cooperation agreements with Hillhouse Ventures and Zhangjiang Group


    .


    Increase R&D investment in China to empower medical industry innovation

    With an investment of more than 200 million yuan, Roche China Accelerator will integrate Roche's own resources and advantages, and provide personalized support plans for start-ups in the fields of innovative drugs, diagnosis, personalized medicine, and artificial intelligence through agile and flexible cooperation methods
    .
    The settled start-ups can obtain Roche's full-chain localized resource support from early R&D to late commercialization, including scientific and technical guidance, business strategy guidance, and operational support


    .


    The new Roche Accelerator Building will be completed and put into use in the first quarter of 2022.
    It is located in Zhangjiang High-tech Park in Pudong New Area, covering an area of ​​more than 5,000 square meters
    .
    In the future, Roche Shanghai Innovation Center and Roche Group’s global R&D scientists will actively participate in and share, provide entrepreneurs with high-quality laboratories and offices, and establish cooperation on the basis of voluntary complementarity between the two parties, and through accelerators, they will nurture a number of global occupations.


    Start-ups in the heights of innovation


    At the launching ceremony, Roche Group CEO Dr.
    Shi Wan and Roche’s global drug research and early development head Dr.
    William Pao expressed their confidence in the Chinese market and expectations of accelerators through online participation
    .
    Dr.


    Schwan said: “The Chinese market is an important part of Roche’s global strategy.


    Dr.


    William Pao also mentioned: “At Roche, we use science to drive the innovation of drugs and medical solutions, and are committed to promoting the accelerated development of global medical innovation


    From global introduction to local incubation, promoting Chinese R&D to the world

    The Roche Group has a history of more than 90 years with China, and has always fulfilled its long-term commitment to China and is committed to providing Chinese patients with first-class differentiated medicines and diagnostic solutions


    .


    Today's Roche China Accelerator is another strategic innovation initiative of Roche following the completion of the Roche Shanghai Innovation Center in 2019
    .
    Roche has joined hands with strategic partners, including Zhangjiang Group, Hillhouse Ventures, etc.


    , to jointly help local incubation


    As an important partner of the accelerator, Zhangjiang Group will provide strong support for the establishment and operation of Roche China Accelerator, Hillhouse Ventures will selectively provide capital support for high-quality start-up companies and projects, and jointly promote the innovation of China's biomedical industry Development


    .


    "Roche is the first multinational pharmaceutical company to settle in Zhangjiang, Shanghai.
    It has been rooted in China for 27 years.
    We have witnessed too many firsts in this land
    .
    " said Ms.
    Zhou Hong, President of Roche Pharmaceuticals China.

    National boundaries .
    The launch of Roche China Accelerator marks an important transition from introducing global innovations to incubating local innovations.
    Roche is committed to building China into a global innovation center
    .
    Adhering to the concept of "walking for patients first", we will continue to do so in the future Work with our partners to build a healthcare ecosystem, promote Chinese R&D to the world, and accelerate the benefit of patients in China and the world
    .
    "

           "As a pioneer in the field of in vitro diagnostics, Roche Diagnostics has always been open to cooperation with local start-ups to empower the construction of China's innovation ecosystem
    .
    Relying on our R&D and commercial strength in the Chinese market, we hope to provide strong support to local companies
    .
    "Roche Diagnostics China General Manager Yao Guoliang said, "In vitro diagnostics plays an important role in all stages of disease management
    .
    With the help of the Roche China Accelerator Project, we are committed to cooperating with local governments and industry partners to research and discover more advanced whole Solutions to promote the development of personalized medicine, so as to bring more well-being to patients
    .
    "

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.